These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31452746)

  • 21. Whole-exome sequencing identifies a novel homozygous frameshift mutation in the PROM1 gene as a causative mutation in two patients with sporadic retinitis pigmentosa.
    Liu S; Xie L; Yue J; Ma T; Peng C; Qiu B; Yang Z; Yang J
    Int J Mol Med; 2016 Jun; 37(6):1528-34. PubMed ID: 27082927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.
    Yu Z; Li A; Wang M
    BMC Bioinformatics; 2016 Aug; 17():310. PubMed ID: 27538789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
    Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
    BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
    Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
    Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of RNA- and exome sequencing: Increasing specificity for identification of somatic point mutations and indels in acute leukaemia.
    Hansen MC; Herborg LL; Hansen M; Roug AS; Hokland P
    Leuk Res; 2016 Dec; 51():27-31. PubMed ID: 27821287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the frequency of inherited germline mutations by whole exome sequencing in ethyl nitrosourea-treated and untreated gpt delta mice.
    Masumura K; Toyoda-Hokaiwado N; Ukai A; Gondo Y; Honma M; Nohmi T
    Genes Environ; 2016; 38():10. PubMed ID: 27350829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
    Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
    Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
    Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML
    Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
    Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
    Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity.
    Braun DA; Schueler M; Halbritter J; Gee HY; Porath JD; Lawson JA; Airik R; Shril S; Allen SJ; Stein D; Al Kindy A; Beck BB; Cengiz N; Moorani KN; Ozaltin F; Hashmi S; Sayer JA; Bockenhauer D; Soliman NA; Otto EA; Lifton RP; Hildebrandt F
    Kidney Int; 2016 Feb; 89(2):468-475. PubMed ID: 26489029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental dysplasia of the hip: linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in all affected members of a large multigeneration family.
    Feldman GJ; Parvizi J; Levenstien M; Scott K; Erickson JA; Fortina P; Devoto M; Peters CL
    J Bone Miner Res; 2013 Dec; 28(12):2540-9. PubMed ID: 23716478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
    Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
    Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of Leber congenital amaurosis in Chinese: New data from 66 probands and mutation overview of 159 probands.
    Xu Y; Xiao X; Li S; Jia X; Xin W; Wang P; Sun W; Huang L; Guo X; Zhang Q
    Exp Eye Res; 2016 Aug; 149():93-99. PubMed ID: 27375279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive multigene mutation spectra of breast cancer patients from Northeast China obtained using the Ion Torrent sequencing platform.
    Fan C; Liu N; Fan S; Yang Z; Ye N; Wang K
    Oncol Rep; 2019 Oct; 42(4):1580-1588. PubMed ID: 31364747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.
    Lee HB; Joung JG; Kim J; Lee KM; Ryu HS; Lee HO; Moon HG; Park WY; Noh DY; Han W
    Cancer Cytopathol; 2015 Nov; 123(11):669-77. PubMed ID: 26265110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.
    Romero Arenas MA; Fowler RG; San Lucas FA; Shen J; Rich TA; Grubbs EG; Lee JE; Scheet P; Perrier ND; Zhao H
    Surgery; 2014 Dec; 156(6):1351-7; discussion 1357-8. PubMed ID: 25456907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
    Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
    BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequencing study on familial lung squamous cancer.
    Li S; Wang L; Ma Z; Ma Y; Zhao J; Peng BO; Qiao Z
    Oncol Lett; 2015 Oct; 10(4):2634-2638. PubMed ID: 26622902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer.
    Xu Y; Xue D; Kyani A; Bankhead A; Roy J; Ljungman M; Neamati N
    ACS Pharmacol Transl Sci; 2023 Aug; 6(8):1164-1181. PubMed ID: 37588763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.